Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $10.0 million.

  • SOPHiA GENETICS's Current Deferred Revenue rose 2319.02% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 2319.02%. This contributed to the annual value of $5.7 million for FY2024, which is 3962.5% down from last year.
  • As of Q3 2025, SOPHiA GENETICS's Current Deferred Revenue stood at $10.0 million, which was up 2319.02% from $9.6 million recorded in Q2 2025.
  • Over the past 5 years, SOPHiA GENETICS's Current Deferred Revenue peaked at $10.0 million during Q3 2025, and registered a low of $3.4 million during Q4 2022.
  • In the last 5 years, SOPHiA GENETICS's Current Deferred Revenue had a median value of $7.4 million in 2023 and averaged $6.9 million.
  • As far as peak fluctuations go, SOPHiA GENETICS's Current Deferred Revenue surged by 17647.06% in 2023, and later tumbled by 3962.5% in 2024.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Current Deferred Revenue stood at $4.1 million in 2021, then dropped by 15.61% to $3.4 million in 2022, then soared by 176.47% to $9.5 million in 2023, then tumbled by 39.63% to $5.7 million in 2024, then surged by 75.16% to $10.0 million in 2025.
  • Its last three reported values are $10.0 million in Q3 2025, $9.6 million for Q2 2025, and $9.8 million during Q1 2025.